IATA announced that it is in the final development phase of the IATA Travel Pass, a digital health pass that will support the safe reopening of borders.
To re-open borders without quarantine and restart aviation governments need to be confident that they are effectively mitigating the risk of importing COVID-19. This means having accurate information on passengers’ COVID-19 health status.
IATA Travel Pass will manage and verify the secure flow of necessary testing or vaccine information among governments, airlines, laboratories, and travellers, the International Air Transport Association (IATA) writes in a press release.
The first cross-border IATA Travel Pass pilot is scheduled for later this year and the launch slated for Q1 2021.
IATA and International Airlines Group (IAG) have collaborated on this solution and will undertake a trial to demonstrate that this platform combined with COVID-19 testing can reopen borders.
IATA Travel Pass incorporates four open sourced and interoperable modules, which can be combined for an end-to-end solution:
- Global registry of health requirements – enables passengers to find accurate information on travel, testing, and eventually vaccine requirements for their journey.
- Global registry of testing/vaccination centers – enables passengers to find testing centers and labs at their departure location which meet the standards for testing and vaccination requirements of their destination.
- Lab App – enables authorized labs and test centers to securely share test and vaccination certificates with passengers.
- Contactless Travel App – enables passengers to (1) create a ‘digital passport’, (2) receive test and vaccination certificates and verify that they are sufficient for their itinerary, and (3) share testing or vaccination certificates with airlines and authorities to facilitate travel.
This app can also be used by travelers to manage travel documentation digitally and seamlessly throughout their journey, improving travel experience. IATA Travel Pass will manage and verify the secure flow of necessary testing or vaccine information among governments, airlines, laboratories, and travellers. to demonstrate that this platform combined with COVID-19 testing can reopen borders.